Johnson L. David's Insider Trades & SAST Disclosures
Johnson L. David's most recent trade in Caribou Biosciences Inc was a trade of 40,500 Option to purchase Common Stock done . Disclosure was reported to the exchange on Feb. 20, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Johnson L. David.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Caribou Biosciences Inc | David L. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 40,500 | 40,500 | - | - | Option to purchase Common Stock | |
| Vera Therapeutics Inc - Or... | David L. Johnson | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 53,800 | 53,800 | - | - | Stock Option (right to buy) | |
| Vera Therapeutics Inc - Or... | David L. Johnson | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 26,900 | 26,900 | - | 0 | Class A Common Stock | |
| Vera Therapeutics Inc - Or... | David L. Johnson | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 160,000 | 160,000 | - | - | Stock Option (right to buy) | |
| Caribou Biosciences Inc | Johnson L. David | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 39,500 | 39,500 | - | - | Option to purchase Common Stock | |
| Caribou Biosciences Inc | David L. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 21,500 | 21,500 | - | - | Option to purchase Common Stock | |
| Caribou Biosciences Inc | David L. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 44,000 | 44,000 | - | - | Option to purchase Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges